Combination of tocolytic agents for inhibiting preterm labour
References
Additional references
Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. The Cochrane Database of Systematic Reviews 2004, Issue 4.
Bryce J, Boschi‐Pinto C, Shibuya K, Black RE, WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 2005;365(9465):1147‐52.
Caritis S. Adverse effects of tocolytic therapy. BJOG: an international journal of obstetrics and gynaecology 2005;112(Suppl 1):74‐8.
Copper RL, Goldenberg RL, Creasy RK, DuBard MB, Davis RO, Entman SS, et al. A multicenter study of preterm birth weight and gestational age‐specific neonatal mortality. American Journal of Obstetrics and Gynecology 1993;168:78‐84.
Costello AM, Osrin D. Micronutrient status during pregnancy and outcomes for newborn infants in developing countries. Journal of Nutrition 2003;133(5):1757S‐1764S.
Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. The Cochrane Database of Systematic Reviews 1998, Issue 1.
Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. The Cochrane Database of Systematic Reviews 2000, Issue 2.
Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. The Cochrane Database of Systematic Reviews 2002, Issue 4.
Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913‐9.
Deeks JJ, Altman DG, Bradbury MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta‐analysis in Context. London: BMJ Books, 2001.
Doret M, Mellier G, Gaucherand P, Saade GR, Benchaib M, Frutoso J, et al. The in vitro effect of dual combinations of ritodrine, nicardipine and atosiban on contractility of pregnant rat myometrium. BJOG: an international journal of obstetrics and gynaecology 2003;110:731‐4.
Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. The Cochrane Database of Systematic Reviews 2002, Issue 3.
Gates S. Methodological Guidelines. In: The Editorial Team. Pregnancy and Childbirth Group. About The Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2.
Gaunekar NN, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. The Cochrane Database of Systematic Reviews 2004, Issue 3.
Goodwin TM, Valenzuela G, Silver H, Hayashi R, Creasy GW, Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. American Journal of Perinatology 1996;13(3):143‐6.
Goodwin TM, Zograbyan A. Oxytocin receptor antagonists: update. Clinics in Perinatology 1998;25(4):859‐71.
Higgins JPY, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. In: The Cochrane Library, Issue 2, 2005. Chichester, UK: John Wiley & Sons, Ltd.
Jobe A. Beneficial interactions of antenatal corticosteroids and postnatal surfactant. Report of the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. National Institutes of Child Health and Human Development. Bethesda MD: US Department of Health and Human Services, 1994:39‐41.
King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. The Cochrane Database of Systematic Reviews 2003, Issue 1.
King J, Flenady V, Cole S, Thornton S. Cyclo‐oxygenase (COX) inhibitors for treating preterm labour. The Cochrane Database of Systematic Reviews 2005, Issue 2.
Langhoff‐Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ 2006;332:937‐9.
Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why?. Lancet 2005;365:891‐900.
Lumley J. Epidemiology of preterm birth. Bailliere's Clinical Obstetrics and Gynaecology 1993;7(3):477‐98.
National Center for Health Statistics. Health, United States, 2004. With chartbook on trends in the health of Americans. Hyattsville, Maryland: COC, 2004.
NHMRC. Clinical Practical Guidelines: Care around preterm birth. Australia: NHMRC, 2000.
National Institute of Child Health and Human Development. Report of the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. Bethesda MD: US Department of Health and Human Services, 1994.
National Institutes of Health. Antenatal corticosteroids revisited: repeat courses. NIH Consensus Development Conference Statement Online 2000 August 17‐18 (accessed March 2006) Vol. 17, issue 2:1‐10.
Office for National Statistics. Mortality statistics: childhood, infant and perinatal. Review of the Registrar General on deaths in England and Wales, 2003. London: Office for National Statistics, 2005.
Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. The Cochrane Database of Systematic Reviews 2005, Issue 3.
Petrou S. The economic consequences of preterm birth during the first 10 years of life. BJOG: an international journal of obstetrics and gynaecology 2005;112(Suppl 1):10‐5.
Royal College of Obstetrics and Gynaecologists. Antenatal corticosteroids to prevent respiratory distress syndrome. RCOG Clinical Guideline No. 7. London: RCOG, 2004.
The Cochrane Collaboration. Review Manager (RevMan). Version 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2003.
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. The Cochrane Database of Systematic Reviews 2006, Issue 3.
Villar J, Mackey ME, Carroli C, Donner A. Meta‐analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Statistics in Medicine 2001;20:3635‐47.
